Varas-Lorenzo C, Arana A, Johannes CB, McQuay LJ, Rothman KJ, Fife D. Improving the identification of out-of-hospital sudden cardiac deaths in a general practice research database. Drugs Real World Outcomes. 2016 Sep;3(3):353-8. doi: 10.1007/s40801-016-0086-1
Arana A, Johannes CB, McQuay LJ, Varas-Lorenzo C, Fife D, Rothman KJ. Risk of out-of-hospital sudden cardiac death in users of domperidone, proton pump inhibitors, or metoclopramide: a population-based nested case-control study. Drug Saf. 2015 Dec;38(12):1187-99. doi: 10.1007/s40264-015-0338-0.
Arana A, Johannes C, Varas-Lorenzo C, Rothman KJ, McQuay LJ, Yang Q, Fife D. Assessment of daily dose of domperidone in the clinical practice research datalink (CPRD) using multiple information sources. Poster presented at the 30th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; October 2014. Taipei, Taiwan. [abstract] Pharmacoepidemiol Drug Saf. 2014 Oct; 23(S1):329.
Arana A, Johannes CB, Varas-Lorenzo C, Rothman KJ, McQuay LJ, Yang Q, Fife D. Risk of out-of-hospital sudden cardiac death with use of domperidone, prototon pump inhibitors, and metoclopramide. Poster presented at the 30th International Conference on Pharmacoepidemiology and Therapeutic Risk Management; October 2014. Taipei, Taiwan. [abstract] Pharmacoepidemiol Drug Saf. 2014 Oct; 23(S1):189.
Arana A, Allen S, Burkowitz J, Fantoni V, Ghatnekar O, Rico MT, Vanhaverbeke N, Wentworth CE, Brosa M, Arellano FM. Infliximab paediatric Crohn's disease educational plan: a European, cross-sectional, multicentre evaluation. Drug Saf. 2010 Jun;33(6):489-501.
Arana A, Allen S, Burkowitz J. Evaluation of the infliximab (Remicade®) pediatric crohn's disease educational plan. Presented at the 25th International Conference on Pharmacoepidemiology; 2009.